We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
+13.09%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$494M
AUM Growth
+$7.76M
Cap. Flow
-$29.3M
Cap. Flow %
-5.94%
Top 10 Hldgs %
20.46%
Holding
182
New
33
Increased
22
Reduced
93
Closed
26

Top Buys

Rank Stock Value
1
TGNA
TEGNA Inc
TGNA
+$7.31M
2
HP icon
Helmerich & Payne
HP
+$7.02M
3
HELE icon
Helen of Troy
HELE
+$6.79M
4
MGRC icon
McGrath RentCorp
MGRC
+$6.5M
5
RBC icon
RBC Bearings
RBC
+$4.9M

Sector Composition

Rank Sector Weight
1 Industrials 18.3%
2 Financials 16.9%
3 Healthcare 13.86%
4 Technology 12.03%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRTA icon
76
Prothena Corp
PRTA
$450M
$2.36M 0.48%
+39,237
New +$2.3M
AMBA icon
77
Ambarella
AMBA
$3.81B
$2.27M 0.46%
27,553
-12,568
-31% -$837K
WD icon
78
Walker & Dunlop
WD
$1.53B
$2.23M 0.45%
28,356
-25,141
-47% -$2.11M
POWI icon
79
Power Integrations
POWI
$3.61B
$2.18M 0.44%
+30,362
New +$2.17M
FOXF icon
80
Fox Factory Holding Corp
FOXF
$886M
$2.17M 0.44%
23,769
-6,689
-22% -$622K
RVNC
81
DELISTED
Revance Therapeutics, Inc.
RVNC
$2.11M 0.43%
114,173
+34,189
+43% +$782K
SIG icon
82
Signet Jewelers
SIG
$3.76B
$2.07M 0.42%
30,440
LNTH icon
83
Lantheus
LNTH
$6.59B
$2.06M 0.42%
40,431
+14,664
+57% +$905K
LAZ icon
84
Lazard
LAZ
$4.31B
$1.95M 0.4%
56,268
MP icon
85
MP Materials
MP
$9.1B
$1.93M 0.39%
79,432
-114,551
-59% -$3.47M
VKTX icon
86
Viking Therapeutics
VKTX
$4B
$1.91M 0.39%
+202,919
New +$906K
MLAB icon
87
Mesa Laboratories
MLAB
$574M
$1.9M 0.39%
11,438
-11,884
-51% -$1.86M
QLYS icon
88
Qualys
QLYS
$6.35B
$1.88M 0.38%
16,789
-15,040
-47% -$1.88M
PAA icon
89
Plains All American Pipeline
PAA
$16.1B
$1.86M 0.38%
158,390
+53,467
+51% +$633K
SYNA icon
90
Synaptics
SYNA
$4.15B
$1.86M 0.38%
19,540
-608
-3% -$58.4K
LEN icon
91
Lennar Class A
LEN
$21.2B
$1.83M 0.37%
20,929
FNB icon
92
FNB Corp
FNB
$6.75B
$1.8M 0.36%
137,624
-43,743
-24% -$586K
CYRX icon
93
CryoPort
CYRX
$762M
$1.79M 0.36%
103,306
-6,559
-6% -$138K
ALL icon
94
Allstate
ALL
$67.5B
$1.78M 0.36%
13,146
+3,425
+35% +$448K
SYF icon
95
Synchrony
SYF
$25.6B
$1.74M 0.35%
+53,033
New +$1.82M
VRDN icon
96
Viridian Therapeutics
VRDN
$2.67B
$1.72M 0.35%
+58,911
New +$1.36M
ARWR icon
97
Arrowhead Research
ARWR
$12.4B
$1.69M 0.34%
41,731
-1,893
-4% -$62.7K
NNI icon
98
Nelnet
NNI
$4.7B
$1.67M 0.34%
18,361
SITM icon
99
SiTime
SITM
$21.8B
$1.61M 0.33%
15,887
-7,800
-33% -$738K
AB icon
100
AllianceBernstein
AB
$3.47B
$1.52M 0.31%
44,294

Similar funds

Moody Aldrich Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Moody Aldrich Partners held 182 positions worth $494M, up 1.6% from $486M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Moody Aldrich Partners withdrew a net $29.3M in Q4 2022, closing 26 positions and reducing 93 holdings. Its most notable exit was Zurn Elkay Water Solutions, an estimated $4.25M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Moody Aldrich Partners opened a new position in TEGNA Inc worth $7.69M.

  • Moody Aldrich Partners's largest Q4 2022 buy was TEGNA Inc: 362,774 shares worth $7.69M.
  • Moody Aldrich Partners added most to RBC Bearings in Q4 2022, an estimated $4.9M increase.
  • Moody Aldrich Partners's biggest Q4 2022 reduction was Independent Bank, cutting an estimated $4.95M.
  • Moody Aldrich Partners fully exited Zurn Elkay Water Solutions in Q4 2022, selling an estimated $4.25M.
  • Moody Aldrich Partners's ten largest holdings make up 20% of its $494M portfolio in Q4 2022.
  • Moody Aldrich Partners opened 33 new positions and closed 26 in Q4 2022.
  • Moody Aldrich Partners's portfolio value rose 1.6% quarter-over-quarter to $494M.

Based on Moody Aldrich Partners's 13F filing for Q4 2022, filed 24 Jan 2023.